Stocks and Investing Stocks and Investing
Mon, December 16, 2019

Yatin Suneja Initiated (ACAD) at Strong Buy and Held Target at $60 on, Dec 16th, 2019


Published on 2024-10-26 19:08:32 - WOPRAI, Yatin Suneja
  Print publication without navigation


Yatin Suneja of Guggenheim, Initiated "ACADIA Pharmaceuticals Inc." (ACAD) at Strong Buy and Held Target at $60 on, Dec 16th, 2019.

Yatin has made no other calls on ACAD in the last 4 months.



There are 7 other peers that have a rating on ACAD. Out of the 7 peers that are also analyzing ACAD, 2 agree with Yatin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jay Olson of "Oppenheimer" Initiated at Hold and Held Target at $44 on, Thursday, October 24th, 2019
  • Paul Matteis of "Stifel" Maintained at Hold with Increased Target to $28 on, Tuesday, September 3rd, 2019


These are the ratings of the 5 analyists that currently disagree with Yatin


  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy with Increased Target to $70 on, Tuesday, November 26th, 2019
  • Gregory Renza of "RBC Capital" Initiated at Buy and Held Target at $60 on, Tuesday, October 1st, 2019
  • Marc Goodman of "SVB Leerink" Upgraded from Hold to Buy and Increased Target to $50 on, Friday, September 13th, 2019
  • Sumant Kulkarni of "Canaccord Genuity" Upgraded from Hold to Strong Buy on, Tuesday, September 10th, 2019
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $60 on, Monday, September 9th, 2019
Contributing Sources